Heptagon Driehaus US Micro Cap Eq C$ Acc |
Performance History | 29/02/2024 |
Growth of 1,000 (EUR) |
Fund | 70.3 | 33.6 | -28.8 | 8.7 | 12.4 | |
+/-Cat | 53.3 | 6.9 | -11.3 | -4.4 | 7.2 | |
+/-Idx | - | 8.7 | -14.4 | -6.1 | 9.3 | |
Category: US Small-Cap Equity | ||||||
Benchmarks: Morningstar US Sml Ext NR USD |
Key Stats | ||
NAV 27/03/2024 | USD 348.49 | |
Day Change | 1.56% | |
Morningstar Category™ | US Small-Cap Equity | |
ISIN | IE00BDB53K54 | |
Fund Size (Mil) 26/03/2024 | USD 839.37 | |
Share Class Size (Mil) 26/03/2024 | USD 248.41 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 01/01/2024 | 1.10% |
Investment Objective: Heptagon Driehaus US Micro Cap Eq C$ Acc |
The investment objective of the Fund is to achieve long-term capital growth. The Fund uses a growth style of investment in equity securities, whereby the Sub-Investment Manager seeks out investments with good growth potential. Under normal market conditions, the Fund will invest at least 80% of its net assets in the equity securities, including common and preferred stocks, of U.S. micro-capitalization (“micro-cap”) companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jeffrey James 07/12/2016 | ||
Michael Buck 07/12/2016 | ||
Click here to see others | ||
Inception Date 07/12/2016 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
Russell Micro Cap Growth TR USD | Morningstar US Sml Ext NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Heptagon Driehaus US Micro Cap Eq C$ Acc | 31/01/2024 |
|
|
Top 5 Holdings | Sector | % |
FTAI Aviation Ltd | Industrials | 3.13 |
Crinetics Pharmaceuticals Inc | Healthcare | 2.60 |
Modine Manufacturing Co | Consumer Cyclical | 2.59 |
Camtek Ltd | Technology | 2.53 |
Xenon Pharmaceuticals Inc | Healthcare | 2.27 |
Increase Decrease New since last portfolio | ||
Heptagon Driehaus US Micro Cap Eq C$ Acc |